Exodus Point Capital Management, LP Neuronetics, Inc. Transaction History
Exodus Point Capital Management, LP
- $9.1 Billion
- Q3 2025
A detailed history of Exodus Point Capital Management, LP transactions in Neuronetics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 72,384 shares of STIM stock, worth $142,596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,384Holding current value
$142,596% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding STIM
# of Institutions
113Shares Held
21.8MCall Options Held
1.58MPut Options Held
213K-
Vanguard Group Inc Valley Forge, PA2.83MShares$5.58 Million0.0% of portfolio
-
Ubs Group Ag2.16MShares$4.26 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.82MShares$3.59 Million0.01% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$3.42 Million1.44% of portfolio
-
Wexford Capital LP Greenwich, CT1.18MShares$2.32 Million0.49% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $53.2M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...